LCTX: Lineage Cell Therapeutics Inc
LCTX exchange rate has changed by -1.63% for today. During the day, the instrument was traded at a low of 1.8100 and at a high of 1.9500.
Follow Lineage Cell Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LCTX News
- H.C. Wainwright reiterates Buy on Lineage Cell stock, $9 target
- Lineage Cell Therapeutics, Inc. (LCTX) Q4 2025 Earnings Call Transcript
- Lineage Cell Therapeutics earnings beat by $0.05, revenue topped estimates
- Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
- Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates
- Pacira (PCRX) Lags Q4 Earnings and Revenue Estimates
- Beyond Meat appoints Tony Kalajian as chief accounting officer
- Lineage Cell Therapeutics highlights 2025 achievements in cell therapy
- Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - ADC Therapeutics (NYSE:ADCT), Capricor Therapeutics (NASDAQ:CAPR)
- Lineage Cell Therapeutics withdraws CIRM grant application, plans resubmission
- Lineage Cell Therapeutics Stock: OpRegen Makes It A Viable Speculative Buy (NYSE:LCTX)
- Lineage Cell Therapeutics sells 12 million shares to Janus Henderson for $21 million
- Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
- Lineage Cell Therapeutics earnings missed by $0.11, revenue topped estimates
- Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
- Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?
- Baird reiterates Outperform rating on Lineage Cell stock after Roche R&D Day
Frequently Asked Questions
What is LCTX stock price today?
Lineage Cell Therapeutics Inc stock is priced at 1.8100 today. It trades within 1.8100 - 1.9500, yesterday's close was 1.8400, and trading volume reached 1992. The live price chart of LCTX shows these updates.
Does Lineage Cell Therapeutics Inc stock pay dividends?
Lineage Cell Therapeutics Inc is currently valued at 1.8100. Dividend policy depends on the company, while investors also watch 5.42% and USD. View the chart live to track LCTX movements.
How to buy LCTX stock?
You can buy Lineage Cell Therapeutics Inc shares at the current price of 1.8100. Orders are usually placed near 1.8100 or 1.8130, while 1992 and -6.22% show market activity. Follow LCTX updates on the live chart today.
How to invest into LCTX stock?
Investing in Lineage Cell Therapeutics Inc involves considering the yearly range 1.6900 - 1.9850 and current price 1.8100. Many compare -4.74% and 5.42% before placing orders at 1.8100 or 1.8130. Explore the LCTX price chart live with daily changes.
What are Lineage Cell Therapeutics Inc stock highest prices?
The highest price of Lineage Cell Therapeutics Inc in the past year was 1.9850. Within 1.6900 - 1.9850, the stock fluctuated notably, and comparing with 1.8400 helps spot resistance levels. Track Lineage Cell Therapeutics Inc performance using the live chart.
What are Lineage Cell Therapeutics Inc stock lowest prices?
The lowest price of Lineage Cell Therapeutics Inc (LCTX) over the year was 1.6900. Comparing it with the current 1.8100 and 1.6900 - 1.9850 shows potential long-term entry points. Watch LCTX moves on the chart live for more details.
When did LCTX stock split?
Lineage Cell Therapeutics Inc has gone through stock splits historically. These changes are visible in , 1.8400, and 5.42% after corporate actions.
- Previous Close
- 1.8400
- Open
- 1.9300
- Bid
- 1.8100
- Ask
- 1.8130
- Low
- 1.8100
- High
- 1.9500
- Volume
- 1.992 K
- Daily Change
- -1.63%
- Month Change
- -4.74%
- 6 Months Change
- 5.42%
- Year Change
- 5.42%